Analysis of Gly40ser polymorphism of the glucagon receptor (GCGR) gene in different ethnic groups

Journal of Human Hypertension

Volumn 17, Issue 8, 2003, Pages 577-579

  Barbato, A ^a   Russo, P ^b   Venezia, A ^b   Strazzullo, V ^c   Siani, A ^b   Cappuccio, F P ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

^b CNR   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCAGON; GLUCAGON RECEPTOR; GLYCINE; SERINE;

AMINO ACID SUBSTITUTION; CLINICAL PROTOCOL; ETHNIC GROUP; GENE FREQUENCY; GENE MUTATION; GENERAL PRACTICE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; HYPERTENSION; LETTER; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION GENETICS; POPULATION RESEARCH; POPULATION RISK; PREVALENCE; PROTEIN SYNTHESIS; RANDOMIZATION; RECEPTOR AFFINITY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCREENING; STATISTICAL ANALYSIS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLYCINE; HUMANS; HYPERTENSION; LONDON; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, GLUCAGON; SERINE;

EID: 0041589769     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001591     Document Type: Letter

References (24)

1. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, and management of cardiovascular risk factors in different ethnic groups in south London. Heart 1997; 78: 555-563.
2. Balarajan R. Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales. BMJ 1991; 302: 560-564.
3. Roderick PJ et al. Population need for renal replacement therapy in Thames regions: Ethnic dimension. BMJ 1994; 309: 1111-1114.
4. Raleigh VS. Diabetes and hypertension in Britain's ethnic minorities: Implications for the future of renal services. BMJ 1997; 314: 209-213.
5. Hager J et al. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus. Nat Genet 1995; 9: 299-304.
6. Gough SC et al. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: Association or founder effect? Hum Mol Genet 1995; 4: 1609-1612.
7. Brand E, Bankir L, Plouin PF, Soubrier F. Glucagon receptor gene mutation (Gly40Ser) in human essential hypertension: The PEGASE study. Hypertension 1999; 34: 15-17.
8. Strazzullo P et al. Altered renal sodium handling and hypertension in men carrying the glucagon receptor gene (Gly40Ser) variant. J Mol Med 2001; 79: 574-580.
9. Chambers SM, Morris BJ. Glucagon receptor gene mutation in essential hypertension. Nat Genet 1996; 12: 122.
10. Hansen LH et al. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon. Diabetes 1996; 45: 725-730.
11. Siani A et al. Gly40Ser polymorphism of the glucagon receptor gene is associated with central adiposity in men. Obes Res 2001; 9: 722-726.
12. Huang X, Orho M, Lehto M, Groop L. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland. Diabetologia 1995; 38: 1246-1248.
13. Ambrosch A et al. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population. Clin Chem Lab Med 1999; 37: 719-721.
14. Shiota D et al. Role of the Gly40Ser mutation in the glucagon receptor gene in Brazilian patients with type 2 diabetes mellitus. Pancreas 2002; 24: 386-390.
15. Ristow M, Busch K, Schatz H, Pfeiffer A. Restricted geographical extension of the association of a glucagon receptor gene mutation (Gly40Ser) with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1996; 32: 183-185.
16. Ogata M et al. Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM. Diabetes Res Clin Pract 1996; 33: 71-74.
17. Odawara M, Tachi Y, Yamashita K. Absence of association between the Gly40→Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance. Hum Genet 1996; 98: 636-639.
18. Deng H, Tang WL, Pan Q. Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality. Hunan Yi Ke Da Xue Xue Bao 2001; 26: 291-293.
19. Cappuccio FP, Cook DG, Atkinson RW, Wicks PD. The Wandsworth Heart and Stroke Study. A population-based survey of cardiovascular risk factors in different ethnic groups. Methods and baseline findings. Nutr Metab Cardiovasc Dis 1998; 8: 371-385.
20. Sagnella GA et al. A population study of ethnic variations in the angiotensin-converting enzyme I/D polymorphism: Relationships with gender, hypertension and impaired glucose metabolism. J Hypertens 1999; 17: 657-664.
21. Morris BJ, Chambers SM. Hypothesis: Glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension. Clin Exp Pharmacol Physiol 1996; 23: 1035-1037.
22. Ahloulay M et al. Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperfiltration in rats. J Clin Invest 1996; 96: 2251-2258.
23. Van Schravendijk CF et al. Pancreatic hormone receptors on islet cells. Endocrinology 1985; 117: 841-848.
24. Cappuccio FP, Sagnella GA, MacGregor GA. Association studies of genetic polymorphisms and complex disease. Lancet 2000; 355: 1278.